Measurement of systemic lupus erythematosus activity in clinical research.
1988
M H Liang, and
S A Socher, and
W N Roberts, and
J M Esdaile
Department of Rheumatology/Immunology, Harvard Medical School, Brigham and Women's Hospital, Robert B. Brigham Multipurpose Arthritis Center, Boston, MA 02115.
UI
MeSH Term
Description
Entries
D008180
Lupus Erythematosus, Systemic
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012219
Rheumatology
A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.
D012720
Severity of Illness Index
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Illness Index Severities,Illness Index Severity
Related Publications
M H Liang, and
S A Socher, and
W N Roberts, and
J M Esdaile